comparemela.com


The real cost of RSV, a common but often fatal disease
RESCEU have put together the most comprehensive cache of evidence to date on the true burden of a disease that still claims millions of mostly infant victims every year 
Image by Blanscape via Shutterstock
 
Anyone can catch respiratory syncytial virus, and most people are infected before their fifth birthday. Symptoms can vary from mild to deadly. Young children are at greatest risk, though it can also be serious for older people and those with other health problems. To try to get the full picture of how much of an impact the disease has on populations and public health systems, a team of researchers, policy makers, pharma sector representatives and patient advocates came together under the RESCEU project to produce an evidence-based tally of the costs of the disease, with the ultimate aim of using the data to feed public health strategies.

Related Keywords

Harish Nair ,Global Health ,Young ,University Of Edinburgh ,World Health Organisation ,Infectious Diseases ,Professor Harish Nair ,Paediatric Infectious Diseases ,Respiratory Viral Epidemiology ,Lancet Infectious Diseases ,European Centres ,Disease Control ,Lancet Infectious ,கடுமையான நாயர் ,உலகளாவிய ஆரோக்கியம் ,இளம் ,பல்கலைக்கழகம் ஆஃப் எடின்பர்க் ,உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,தொற்று நோய்கள் ,ப்ரொஃபெஸர் கடுமையான நாயர் ,குழந்தை தொற்று நோய்கள் ,ஐரோப்பிய மையங்கள் ,நோய் கட்டுப்பாடு ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.